CIK 0001509261 · Non-accelerated filer<br>Smaller reporting company
Rezolute, Inc.
Sign in to watch- Ticker
- RZLT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Jun 30
- Incorporated
- NV
- Entity type
- operating
- EIN
- 273440894
- Phone
- 650-206-4507
- Business address
- 275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY, CA, 94065
- Former names
- AntriaBio, Inc., FITS MY STYLE INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-07-09 | HANDOK, INC. 10% owner | Purchase | +133,804 | $0.13 | $17K | 91,825,037 |
| 2020-07-08 | HANDOK, INC. 10% owner | Purchase | +45,200 | $0.12 | $5K | 91,691,233 |
| 2020-07-07 | HANDOK, INC. 10% owner | Purchase | +45,100 | $0.11 | $5K | 91,646,033 |
| 2020-07-06 | HANDOK, INC. 10% owner | Purchase | +300,000 | $0.10 | $30K | 91,600,933 |
| 2019-07-31 | Vendola Keith A. Chief Financial Officer | Grant or award · Stock Option (right to buy) | +3,000,000 | 3,000,000 | ||
| 2019-07-31 | Mantripragada Sankaram Chief Scientific Officer | Grant or award · Stock Option (right to buy) | +3,500,000 | 3,500,000 | ||
| 2019-07-31 | Elam Nevan C Chief Executive Officer | Grant or award · Stock Option (right to buy) | +15,000,000 | 15,000,000 | ||
| 2019-07-23 | Genexine Inc. 10% owner | Purchase | +34,482,758 | $0.29 | $10.0M | 91,300,933 |
| 2019-07-23 | HANDOK, INC. 10% owner | Purchase | +34,482,758 | $0.29 | $10.0M | 91,300,933 |
| 2019-04-26 | Genexine Inc. 10% owner | Conversion | +56,818,175 | 56,818,175 | ||
| 2019-04-26 | Genexine Inc. 10% owner | Conversion · Series AA Preferred Stock | −1,250,000 | $10.00 | $12.5M | 0 |
| 2019-04-26 | HANDOK, INC. 10% owner | Conversion | +56,818,175 | 56,818,175 | ||
| 2019-04-26 | HANDOK, INC. 10% owner | Conversion · Series AA Preferred Stock | −1,250,000 | $10.00 | $12.5M | 0 |
| 2017-03-10 | Welch David F Director | Purchase | +5,000 | $0.95 | $5K | 1,811,415 |
| 2017-03-09 | Welch David F Director | Purchase | +5,000 | $0.95 | $5K | 1,806,415 |
| 2017-03-08 | Welch David F Director | Purchase | +5,000 | $0.98 | $5K | 1,801,415 |
| 2017-03-06 | Welch David F Director | Purchase | +5,000 | $0.95 | $5K | 1,796,415 |
| 2017-02-10 | Welch David F Director | Purchase | +5,000 | $0.99 | $5K | 28,100 |
| 2017-02-09 | Welch David F Director | Purchase | +3,100 | $0.97 | $3K | 23,100 |
| 2017-02-08 | Welch David F Director | Purchase | +5,000 | $0.98 | $5K | 20,000 |
Page 12 of 14 · 279 trades